Eugia Pharma Receives USFDA Approval for Vasopressin Injection USP, 20 units/‌mL, 1 mL MDV

Eugia US is pleased to announce that the company has received approval from the US Food & Drug Administration (USFDA) to manufacture and market Vasopressin Injection USP, 20 units/‌mL, I mL MDV.

Indications for this product include:

• To increase blood pressure in adults with vasodilatory shock who remain hypotensive despite fluids and catecholamines.

Refer to package insert for full prescribing information.